Crucial Data Soutions
OCTOBER 25, 2024
In clinical research, the advent of artificial intelligence (AI) is transforming the way study teams approach their work. AI is. The post The Digital Teammate: How AI is Changing How Clinical Research Teams Work appeared first on Crucial Data Solutions.
Pharmaceutical Technology
OCTOBER 25, 2024
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 25, 2024
The British pharma is making what it calls its largest U.S. manufacturing investment. Elsewhere, AbbVie expanded a longstanding partnership and Marinus said it would lay off staff.
Pharmaceutical Technology
OCTOBER 25, 2024
The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with fibrostenosing Crohn’s disease.
Speaker: Simran Kaur, Founder & CEO at Tattva Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
OCTOBER 25, 2024
Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped during the third quarter.
Pharmaceutical Technology
OCTOBER 25, 2024
Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at decarbonisation across the healthcare ecosystem.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 25, 2024
Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological diseases.
pharmaphorum
OCTOBER 25, 2024
Intellia reports a big reduction in hereditary angioedema attacks in patients treated with its one-shot CRISPR drug, but its share fall sharply
Pharmaceutical Technology
OCTOBER 25, 2024
A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.
Fierce Pharma
OCTOBER 25, 2024
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum Therapeutics has scored a green light for its oral antibiotic sulopenem. | Iterum's Orlynvah was approved by the FDA Friday to treat certain uncomplicated urinary tract infections (uUTIs) in adult women who have limited or no alternative antibacterial treatment options.
Pharmaceutical Technology
OCTOBER 25, 2024
The Phase III ECZTEND study reported that patients treated with Adbry demonstrated long term safety and efficacy for up to six years.
Fierce Pharma
OCTOBER 25, 2024
Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. | Johnson & Johnson tested Tremfya in patients with plaque psoriasis involvement in "sensitive or highly visible areas," while Lilly weighed Ebglyss in atopic dermatitis patients who've previously tried Dupixent.
Pharmaceutical Technology
OCTOBER 25, 2024
New research casts doubt on current advice recommending AF patients wait up to 14 days to receive anticoagulants after a stroke.
pharmaphorum
OCTOBER 25, 2024
MSD buys Modifi Bio in a $1.3bn deal, getting rights to a new class of drugs for difficult-to-treat cancers, including glioblastoma.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 25, 2024
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.
Fierce Pharma
OCTOBER 25, 2024
Despite Merck & Co. | Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus antibody clesrovimab, Sanofi thinks Beyfortus can hold its own. On a Friday call with analysts, Sanofi execs pointed to an efficacy edge for its preventive and stressed that more competition in the space is a net positive.
Pharmaceutical Technology
OCTOBER 25, 2024
The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.
Fierce Pharma
OCTOBER 25, 2024
A senior executive at BeiGene is under investigation by Chinese authorities, multiple local media outlets report. | A senior executive at BeiGene is under investigation by Chinese authorities, multiple local media outlets report. The company said it believes the investigation is not related to its activities.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
pharmaphorum
OCTOBER 25, 2024
NICE backs two AI algorithms from Boston Scientific and Medtronic for monitoring heart failure patients, but turns down others from Biotronik and Abbott.
XTalks
OCTOBER 25, 2024
Shields Health Solutions, a specialty pharmacy owned by Walgreens, has partnered with Sutter Health to expand access to specialty medications across the US. This collaboration aims to support patients with chronic and complex conditions, particularly in oncology, rheumatology and dermatology. Nearly 3,000 healthcare providers will benefit, as Shields’ broad payer network and access to limited distribution drugs will offer patients more treatment options and cost-saving support.
Pharma Marketing Network
OCTOBER 25, 2024
In an era wher Pharmaceutical digital marketing is in the middle of a rapid transformation. For pharma marketing executives , reaching audiences in meaningful, personalized ways has never been more critical. But with complex regulations, fast-evolving digital tools, and the challenges of building trust, it’s tough to know where to start. In this guide, we’ll break down the essentials of pharmaceutical digital marketing to help you navigate the unique challenges of the industry and maximize your
Antidote
OCTOBER 25, 2024
October is National Health Literacy Month, a time to focus on how we can improve a person’s understanding of the health and medical information shared with them. Antidote’s Senior Manager of Digital Marketing, Sean Irvine, shared his thoughts on the importance of health literacy and how we can create more patient-first recruitment campaigns. Read our Q&A session below!
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
OCTOBER 25, 2024
Join top experts in the field of mRNA analytical development and quality control at the 4th summit on February 25-27, 2025. Stay updated on the latest trends and innovations in this cutting-edge industry.
Pharmaceutical Commerce
OCTOBER 25, 2024
Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.
pharmaphorum
OCTOBER 25, 2024
Explore the potential of AI in navigating the vast amounts of data in clinical trials. Discover how this technology is revolutionising the healthcare industry, in a new Tech & Trials column.
Pharmaceutical Commerce
OCTOBER 25, 2024
Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.
XTalks
OCTOBER 25, 2024
Abbott has announced the commencement of a new clinical trial for its advanced left ventricular assist device (LVAD), the HeartMate 3, to determine the benefits of early implantation of the device in patients with advanced heart failure. In a press release announcing the trial, Abbott said the trial is a “first-of-its-kind” to identify advanced heart failure patients who could potentially benefit from early advanced therapy options, the HeartMate 3 in this case.
Pharmaceutical Commerce
OCTOBER 25, 2024
The latest news for pharma industry insiders.
Expert insights. Personalized for you.
52 
Let's personalize your content